In vivo assay for tumor cell invasion.

Lorena Hernandez, Tatiana Smirnova, Jeffrey Wyckoff, John S. Condeelis, Jeffrey E. Segall

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We describe an in vivo invasion assay that enables the collection of invasive cells from the primary tumor. In addition to determination of the endogenous, unstimulated invasive properties of cells in vivo, the assay can take advantage of the chemotactic properties of cancer cells. Microneedles are filled with a mixture of extracellular matrix components such as Matrigel with or without a chemoattractant such as EGF, and then introduced into the primary tumor of a rat or mouse that is generated either by orthotopic injection of carcinoma cell lines or by a transgene such as polyoma Middle T. Over the course of 4 h the invasive cell population enters the needles while the animal is kept under anesthesia. At the end of the collection time, the invasive cells are extruded from the microneedles and can be analyzed in terms of the number and type of cells that invade in response to defined stimuli. By including pharmacological inhibitors in the needle, signaling pathways contributing to in vivo invasion can also be identified. This assay leads to a better understanding of the cell types and signaling involved in the tumor microenvironment, and has the potential to be applied to a variety of in vivo models.

Original languageEnglish (US)
Pages (from-to)227-238
Number of pages12
JournalMethods in molecular biology (Clifton, N.J.)
Volume571
StatePublished - 2009

Fingerprint

Neoplasms
Needles
Tumor Microenvironment
Chemotactic Factors
Transgenes
Epidermal Growth Factor
Extracellular Matrix
Anesthesia
Cell Count
Pharmacology
Carcinoma
Cell Line
Injections
Population
matrigel

ASJC Scopus subject areas

  • Medicine(all)

Cite this

In vivo assay for tumor cell invasion. / Hernandez, Lorena; Smirnova, Tatiana; Wyckoff, Jeffrey; Condeelis, John S.; Segall, Jeffrey E.

In: Methods in molecular biology (Clifton, N.J.), Vol. 571, 2009, p. 227-238.

Research output: Contribution to journalArticle

Hernandez, Lorena ; Smirnova, Tatiana ; Wyckoff, Jeffrey ; Condeelis, John S. ; Segall, Jeffrey E. / In vivo assay for tumor cell invasion. In: Methods in molecular biology (Clifton, N.J.). 2009 ; Vol. 571. pp. 227-238.
@article{ceed48b7c48347f88b9dd3b104958d3c,
title = "In vivo assay for tumor cell invasion.",
abstract = "We describe an in vivo invasion assay that enables the collection of invasive cells from the primary tumor. In addition to determination of the endogenous, unstimulated invasive properties of cells in vivo, the assay can take advantage of the chemotactic properties of cancer cells. Microneedles are filled with a mixture of extracellular matrix components such as Matrigel with or without a chemoattractant such as EGF, and then introduced into the primary tumor of a rat or mouse that is generated either by orthotopic injection of carcinoma cell lines or by a transgene such as polyoma Middle T. Over the course of 4 h the invasive cell population enters the needles while the animal is kept under anesthesia. At the end of the collection time, the invasive cells are extruded from the microneedles and can be analyzed in terms of the number and type of cells that invade in response to defined stimuli. By including pharmacological inhibitors in the needle, signaling pathways contributing to in vivo invasion can also be identified. This assay leads to a better understanding of the cell types and signaling involved in the tumor microenvironment, and has the potential to be applied to a variety of in vivo models.",
author = "Lorena Hernandez and Tatiana Smirnova and Jeffrey Wyckoff and Condeelis, {John S.} and Segall, {Jeffrey E.}",
year = "2009",
language = "English (US)",
volume = "571",
pages = "227--238",
journal = "Methods in Molecular Biology",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - In vivo assay for tumor cell invasion.

AU - Hernandez, Lorena

AU - Smirnova, Tatiana

AU - Wyckoff, Jeffrey

AU - Condeelis, John S.

AU - Segall, Jeffrey E.

PY - 2009

Y1 - 2009

N2 - We describe an in vivo invasion assay that enables the collection of invasive cells from the primary tumor. In addition to determination of the endogenous, unstimulated invasive properties of cells in vivo, the assay can take advantage of the chemotactic properties of cancer cells. Microneedles are filled with a mixture of extracellular matrix components such as Matrigel with or without a chemoattractant such as EGF, and then introduced into the primary tumor of a rat or mouse that is generated either by orthotopic injection of carcinoma cell lines or by a transgene such as polyoma Middle T. Over the course of 4 h the invasive cell population enters the needles while the animal is kept under anesthesia. At the end of the collection time, the invasive cells are extruded from the microneedles and can be analyzed in terms of the number and type of cells that invade in response to defined stimuli. By including pharmacological inhibitors in the needle, signaling pathways contributing to in vivo invasion can also be identified. This assay leads to a better understanding of the cell types and signaling involved in the tumor microenvironment, and has the potential to be applied to a variety of in vivo models.

AB - We describe an in vivo invasion assay that enables the collection of invasive cells from the primary tumor. In addition to determination of the endogenous, unstimulated invasive properties of cells in vivo, the assay can take advantage of the chemotactic properties of cancer cells. Microneedles are filled with a mixture of extracellular matrix components such as Matrigel with or without a chemoattractant such as EGF, and then introduced into the primary tumor of a rat or mouse that is generated either by orthotopic injection of carcinoma cell lines or by a transgene such as polyoma Middle T. Over the course of 4 h the invasive cell population enters the needles while the animal is kept under anesthesia. At the end of the collection time, the invasive cells are extruded from the microneedles and can be analyzed in terms of the number and type of cells that invade in response to defined stimuli. By including pharmacological inhibitors in the needle, signaling pathways contributing to in vivo invasion can also be identified. This assay leads to a better understanding of the cell types and signaling involved in the tumor microenvironment, and has the potential to be applied to a variety of in vivo models.

UR - http://www.scopus.com/inward/record.url?scp=74049113259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74049113259&partnerID=8YFLogxK

M3 - Article

C2 - 19763970

AN - SCOPUS:74049113259

VL - 571

SP - 227

EP - 238

JO - Methods in Molecular Biology

JF - Methods in Molecular Biology

SN - 1064-3745

ER -